Orloff, M. M., Moser, J. C., Shoushtari, A., Betof, A., Davar, D., Chandra, S., Ikeguchi, A., Salama, A. K., Sullivan, R. J., Khan, S., Patel, S. P., Joshua, A. M., Hassel, J. C., Agbaje-Williams, M., Navarro, M., Marpadga, R., Gullo, G., Sacco, J. J. (2026). A randomized, phase 2/3 clinical trial investigating RP2 plus nivolumab vs ipilimumab plus nivolumab in immune checkpoint inhibitor–naïve patients with metastatic uveal melanoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9598